University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease.
May 26, 2015
0
14
One of the least understood effects of COVID-19 infection is "brain fog," a kind of mental confusion that can take hold among seriously ill patients, sometimes lingering long after recovery.
Feb 17, 2021
0
18
Having a moderate or severe traumatic brain injury (TBI) in middle-age is associated with an increased risk for future dementia, according to a retrospective of study of more than 40,000 TBI patients published in PLOS Medicine ...
Jul 5, 2017
0
96
Research led by Nicolas Bazan, MD, Ph.D., Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, found a new mechanism by which a class of molecules his lab discovered ...
Nov 11, 2019
0
203
The active ingredient in an over-the-counter skin cream might do more than prevent wrinkles. Scientists have discovered that the drug, called kinetin, also slows or stops the effects of Parkinson's disease on brain cells.
Aug 16, 2013
0
0
People who get dizzy several minutes after standing up may be at risk of more serious conditions and even an increased risk of death, according to new research published in the September 23, 2015, online issue of Neurology, ...
Sep 23, 2015
0
18
Tiny brains-in-a-dish that mimic the major pathological features of Parkinson's disease have been made for the first time. The research, led by scientists from the Agency for Science, Technology and Research (A*STAR)'s Genome ...
Sep 6, 2021
0
101
Korea Brain Research Institute (KBRI, President Pann Ghill Suh) announced on Mar. 4 that its research team led by principal researcher Yoichi Kosodo has developed a technology to mass produce cerebral cortex neurons utilizing ...
Mar 28, 2019
0
2
Researchers at the University of Pittsburgh, UPMC and Carnegie Mellon University are putting together a study of degenerative brain disorders that have been linked to head injuries, the first project of its kind among the ...
Jun 6, 2016
0
269
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
